Stock analysis, price data, and AI-powered insights for Elevance Health (ELV).
Elevance Health operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ELV.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ELV Stock Intelligence Report. [stoxpulse.com/stocks/elv]
Disclaimer: The information on this page about Elevance Health (ELV) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Elevance Health.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 15%
Mar 31
Dixon sold 151 shares
3d ago
Penczek bought 654 shares
May 19
1 Mooning Stock Worth Your Attention and 2 We Ign...
3d ago
Elevance Health, Inc. (ELV) Presents at Goldman Sa...
3d ago
StoxPulse AI results for ELV: Pulse Score 56/100. Primary sentiment trends from 6 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$87.75B
P/E Ratio
16.0
EPS
$8.00
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
-2.3%
Sep 25
+21.0%
Dec 25
+6.5%
Mar 26
+15.1%
Beat estimates 3 of 4 quarters (75%)
Sector
Healthcare
Industry
Managed Health Care
1 Mooning Stock Worth Your Attention and 2 We Ignore
Elevance Health, Inc. (ELV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Forget AI: Legendary Value Investor Seth Klarman Likes This Heathcare Stock in 2026
Elevance Health expects FY2026 GAAP EPS of at least $19.85 per share; Reaffirms Adj EPS of at least $26.75 per share.
Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $465
Is Elevance (ELV) Turning Digital Access Into a Durable Edge in Medicaid-Centric Care?